April 17, 2024
TOPLINE: Antidepressant prescribing was highly associated with increased mortality in people with type 2 diabetes (T2D). However, the authors suspect that rather than a causal effect, […]
April 17, 2024
TOPLINE: Less than 7 hours of sleep per night is common in individuals with type 1 diabetes (T1D) but is tied to poor cardiometabolic health, particularly […]
April 17, 2024
TOPLINE: Short-term supplementation with a selective essential amino acid (EAA) formulation may reduce liver fat and aspartate aminotransferase (AST) and plasma triglyceride concentrations in adolescent girls […]
April 17, 2024
TOPLINE: Results of the SUMMIT study confirm the association between exposure to high altitude and the occurrence of cardiac arrhythmia, with more than one in three […]
April 17, 2024
TOPLINE: New-onset hypertension was associated with a 45% greater risk of developing fibroids than among women with no history of hypertension, according to a new study. […]
April 17, 2024
TOPLINE: Guselkumab shows early and durable improvement in joint symptoms, spinal pain, and skin clearance through 2 years in biologic-naive patients with active psoriatic arthritis (PsA), […]
April 16, 2024
TOPLINE: An analysis of molecular-targeted cancer drug therapies recently approved in the United States found that fewer than one third demonstrated substantial clinical benefits at the […]
April 16, 2024
TOPLINE: Among people with type 2 diabetes (T2D) using insulin, sodium-glucose cotransporter 2 inhibitors (SGLT2is) were associated with a reduced risk for diabetic macular oedema (DMO) […]
April 16, 2024
TOPLINE: Continuous glucose monitoring (CGM) data provide a more comprehensive characterization of glucose values than fasting glucose (FG) measurement alone. Considerable FG variability was seen even […]